Luteotrophic and luteolytic effects of nitric oxide in sheep are dose-dependent in vivo

Domestic Animal Endocrinology

Volumn 35, Issue 1, 2008, Pages 74-80

  Keator, Christopher S ^a   Schreiber, David T ^a   Hoagland, Thomas A ^a   McCracken, John A ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Corpus luteum; Dipropylenetriamine NONOate; Nitric oxide; Ovarian transplant sheep; Progesterone

Indexed keywords

ALKENE; DIPROPYLENETRIAMINE NONOATE; DIPROPYLENETRIAMINE-NONOATE; NITRIC OXIDE; NITRIC OXIDE DONOR; PROGESTERONE;

ANIMAL; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORPUS LUTEUM; DOSE RESPONSE; DRUG EFFECT; FEMALE; GROWTH, DEVELOPMENT AND AGING; LUTEAL PHASE; LUTEOLYSIS; OVARY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SHEEP; TIME; TRANSPLANTATION;

ALKENES; ANIMALS; CORPUS LUTEUM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; LUTEAL PHASE; LUTEOLYSIS; NITRIC OXIDE; NITRIC OXIDE DONORS; OVARY; PROGESTERONE; SHEEP; TIME FACTORS;

OVIS ARIES;

EID: 44649105770     PISSN: 07397240     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.domaniend.2008.02.001     Document Type: Article

References (52)

1. Friden B.E., Runesson E., Hahlin M., and Brannstrom M. Evidence for nitric oxide acting as a luteolytic factor in the human corpus luteum. Mol Hum Reprod 6 (2000) 397-403
2. Motta A.B., Estevez A., and de Gimeno M.F. The involvement of nitric oxide in corpus luteum regression in the rat: feedback mechanism between prostaglandin F(2alpha) and nitric oxide. Mol Hum Reprod 5 (1999) 1011-1016
3. Boiti C., Guelfi G., Zampini D., Brecchia G., Gobbetti A., and Zerani M. Regulation of nitric oxide synthase isoforms and role of nitric oxide during prostaglandin F2 alpha-induced luteolysis in rabbits. Reproduction 125 (2003) 807-816
4. Jaroszewski J.J., and Hansel W. Intraluteal administration of a nitric oxide synthase blocker stimulates progesterone and oxytocin secretion and prolongs the life span of the bovine corpus luteum. Proc Soc Exp Biol Med 224 (2000) 50-55
5. Skarzynski D.J., Jaroszewski J.J., Bah M.M., Deptula K.M., Barszczewska B., Gawronska B., et al. Administration of a nitric oxide synthase inhibitor counteracts prostaglandin F2 alpha-induced luteolysis in cattle. Biol Reprod 68 (2003) 1674-1681
6. Dong Y.L., Gangula P.R., and Fang L. Nitric oxide reverses prostaglandin-induced inhibition in ovarian progesterone secretion in rats. Hum Reprod 14 (1999) 27-32
7. Motta A.B., Estevez A., Tognetti T., Gimeno M.A., and Franchi A.M. Dual effects of nitric oxide in functional and regressing rat corpus luteum. Mol Hum Reprod 7 (2001) 43-47
8. Kim B.H., Kim C.H., Jung K.Y., Jeon B.H., Ju E.J., and Choo Y.K. Involvement of nitric oxide during in vitro fertilization and early embryonic development in mice. Arch Pharm Res 27 (2004) 86-93
9. Jablonka-Shariff A., Ravi S., Beltsos A.N., Murphy L.L., and Olson L.M. Abnormal estrous cyclicity after disruption of endothelial and inducible nitric oxide synthase in mice. Biol Reprod 61 (1999) 171-177
10. Weems Y.S., Lennon E., Uchima T., Raney A., Goto K., Ong A., et al. Is nitric oxide luteolytic or antiluteolytic?. Prostaglandins Other Lipid Mediat 78 (2005) 129-138
11. Al-Gubory K.H., Ceballos-Picot I., Nicole A., Bolifraud P., Germain G., Michaud M., et al. Changes in activities of superoxide dismutase, nitric oxide synthase, glutathione-dependent enzymes and the incidence of apoptosis in sheep corpus luteum during the estrous cycle. Biochem Biophys Acta 1725 (2005) 348-357
12. Vonnahme K.A., Redmer D.A., Borowczyk E., Bilski J.J., Luther J.S., Johnson M.L., et al. Vascular composition, apoptosis, and expression of angiogenic factors in the corpus luteum during prostaglandin F2alpha-induced regression in sheep. Reproduction 131 (2006) 1115-1126
13. Goding J.R., McCracken J.A., and Baird D.T. The study of ovarian function in the ewe by means of a vascular autotransplantation technique. J Endocrinol 39 (1967) 37-52
14. McCracken J.A., Custer E.E., and Lamsa J.C. Luteolysis: a neuroendocrine-mediated event. Physiol Rev 79 (1999) 263-323
15. Lamsa J.C., Kot S.J., Eldering J.A., Nay M.G., and McCracken J.A. Prostaglandin F2 alpha-stimulated release of ovarian oxytocin in the sheep in vivo: threshold and dose dependency. Biol Reprod 40 (1989) 1215-1223
16. McCracken J.A., Baird D.T., and Goding J.R. Factors affecting the secretion of steroids from the transplanted ovary in the sheep. Recent Prog Horm Res 27 (1971) 537-582
17. Beal W.E., Milvae R.A., and Hansel W. Oestrous cycle length and plasma progesterone concentrations following administration of prostaglandin F-2 alpha early in the bovine oestrous cycle. J Reprod Fertil 59 (1980) 393-396
18. Sokal R.R., and Rohlf F.J. Introduction to biostatistics. 2nd ed. (1987), W.H. Freeman and Company, New York, NY
19. ® 9.1 user's guide vols. 1 and 2 (2004), SAS Institute Inc., Cary, NC
20. Whitley E., and Ball J. Statistics review 1: presenting and summarising data. Crit Care 6 (2002) 66-71
21. Tsuchiya K., Kirima K., Yoshizumi M., and Tamaki T. New methods to evaluate endothelial function: evaluation of endothelial function by hemoglobin-nitric oxide complex using electron paramagnetic resonance spectroscopy. J Pharmacol Sci 93 (2003) 417-422
22. Jeffers A., Xu X., Huang K.T., Cho M., Hogg N., Patel R.P., et al. Hemoglobin mediated nitrite activation of soluble guanylyl cyclase. Comp Biochem Physiol A Mol Integr Physiol 142 (2005) 130-135
23. Grubina R., Huang Z., Shiva S., Joshi M.S., Azarov I., Basu S., et al. Concerted nitric oxide formation and release from the simultaneous reactions of nitrite with deoxy- and oxyhemoglobin. J Biol Chem 282 (2007) 12916-12927
24. Cerra M.C., and Pellegrino D. Cardiovascular cGMP-generating systems in physiological and pathological conditions. Curr Med Chem 14 (2007) 585-599
25. Li H., and Poulos T.L. Structure-function studies on nitric oxide synthases. J Inorg Biochem 99 (2005) 293-305
26. Kim J.S., Ohshima S., Pediaditakis P., and Lemasters J.J. Nitric oxide: a signaling molecule against mitochondrial permeability transition- and pH-dependent cell death after reperfusion. Free Radic Biol Med 37 (2004) 1943-1950
27. Stone J.R., and Marletta M.A. Spectral and kinetic studies on the activation of soluble guanylate cyclase by nitric oxide. Biochemistry 35 (1996) 1093-1099
28. Moncada S., and Erusalimsky J.D. Does nitric oxide modulate mitochondrial energy generation and apoptosis?. Nat Rev Mol Cell Biol 3 (2002) 214-220
29. Xu W., Charles I.G., and Moncada S. Nitric oxide: orchestrating hypoxia regulation through mitochondrial respiration and the endoplasmic reticulum stress response. Cell Res 15 (2005) 63-65
30. Moncada S., and Higgs E.A. The discovery of nitric oxide and its role in vascular biology. Br J Pharmacol 147 Suppl 1 (2006) S193-S201
31. Carreras M.C., and Poderoso J.J. Mitochondrial nitric oxide in the signaling of cell integrated responses. Am J Physiol Cell Physiol 292 (2007) C1569-C1580
32. Nisoli E., Falcone S., Tonello C., Cozzi V., Palomba L., Fiorani M., et al. Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals. Proc Natl Acad Sci USA 101 (2004) 16507-16512
33. Schubert W., Frank P.G., Woodman S.E., Hyogo H., Cohen D.E., Chow C.W., et al. Microvascular hyperpermeability in caveolin-1(-/-) knock-out mice. Treatment with a specific nitric-oxide synthase inhibitor, l-NAME, restores normal microvascular permeability in Cav-1 null mice. J Biol Chem 277 (2002) 40091-40098
34. Parton R.G., and Simons K. The multiple faces of caveolae. Nat Rev Mol Cell Biol 8 (2007) 185-194
35. von Eckardstein A., Hersberger M., and Rohrer L. Current understanding of the metabolism and biological actions of HDL. Curr Opin Clin Nutr Metab Care. 8 (2005) 147-152
36. Garcia X., and Stein F. Nitric oxide. Semin Pediatr Infect Dis 17 (2006) 55-57
37. Giulivi C., Kato K., and Cooper C.E. Nitric oxide regulation of mitochondrial oxygen consumption. I. Cellular physiology. Am J Physiol Cell Physiol 291 (2006) C1225-C1231
38. Stocco D.M. StAR protein and the regulation of steroid hormone biosynthesis. Annu Rev Physiol 63 (2001) 193-213
39. Pescador N., Soumano K., Stocco D.M., Price C.A., and Murphy B.D. Steroidogenic acute regulatory protein in bovine corpora lutea. Biol Reprod 55 (1996) 485-491
40. Towle T.A., Tsang P.C.W., Milvae R.A., Newbury M.K., and McCracken J.A. Dynamic in vivo changes in tissue inhibitors of metalloproteinases 1 and 2, and matrix metalloproteinases 2 and 9, during prostaglandin F(2alpha)-induced luteolysis in sheep. Biol Reprod 66 (2002) 1515-1521
41. McCracken J.A. Prostaglandin F2a: the luteolytic hormone. In: Curtis-Prior P. (Ed). The eicosanoids (2004), John Wiley & Sons, New York, NY 525-545
42. 2α identified as a luteolytic hormone in sheep. Nat New Biol 238 (1972) 129-134
43. McCracken J.A. Prostaglandins and leukotrienes: locally acting agents. In: Conn P.M., and Melmed S. (Eds). Endocrinology: fundamental and clinical principles (2005), Humana Press, Totowa, NJ 93-111
44. Joyce J.M., Phernetton T.M., Shaw C.E., Modrick M.L., and Magness R.R. Endothelial vasodilator production by uterine and systemic arteries. IX. eNOS gradients in cycling and pregnant ewes. Am J Physiol Heart Circ Physiol 282 (2002) H342-H348
45. Vonnahme K.A., Wilson M.E., Li Y., Rupnow H.L., Phernetton T.M., Ford S.P., et al. Circulating levels of nitric oxide and vascular endothelial growth factor throughout ovine pregnancy. J Physiol 565 (2005) 101-109
46. Weems Y.S., Lennon E., Uchima T., Raney A., Goto K., Ong A., et al. Mechanism whereby nitric oxide (NO) infused chronically intrauterine in ewes is antiluteolytic rather than being luteolytic. Prostaglandins Other Lipid Mediat 85 (2008) 33-41
47. α and nitric oxide on the secretory function of bovine luteal cells. J Reprod Dev 50 (2004) 411-417
48. Skarzynski D.J., Kobayashi S., and Okuda K. Influence of nitric oxide and noradrenaline on prostaglandin F(2)(alpha)-induced oxytocin secretion and intracellular calcium mobilization in cultured bovine luteal cells. Biol Reprod 63 (2000) 1000-1005
49. Jaroszewski J.J., Bogacki M., and Skarzynski D.J. Progesterone production in bovine luteal cells treated with drugs that modulate nitric oxide production. Reproduction 125 (2003) 389-395
50. Rekawiecki R., Nowik M., and Kotwica J. Stimulatory effect of LH, PGE2 and progesterone on StAR protein, cytochrome P450 cholesterol side chain cleavage and 3beta hydroxysteroid dehydrogenase gene expression in bovine luteal cells. Prostaglandins Other Lipid Mediat 78 (2005) 169-184
51. Rintoul G.L., Bennett V.J., Papaconstandinou N.A., and Reynolds I.J. Nitric oxide inhibits mitochondrial movement in forebrain neurons associated with disruption of mitochondrial membrane potential. J Neurochem 97 (2006) 800-806
52. Okawa T., Asano K., Takahashi H., Sato A., Vedernikov Y.P., Saade G.R., et al. Nitric oxide donor-induced inhibition of pregnant rat uterine spontaneous contractile activity and release of nitric oxide from uterus measured by microdialysis. J Endocrinol Invest 28 (2005) 998-1002